Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H-H Peter

Showing results (351-360 of 361) with videos related to

Pageof 37
Sort By:
The Journal of Rheumatology|August 24, 2000
Poly(ADP-ribose) polymerase polymorphisms are not a genetic risk factor for systemic lupus erythematosus in German CaucasiansP Boorboor, B E Drescher, K Hartung, et al.
The American Journal of Medicine|November 27, 1998
Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical featuresC Roozendaal, A W Van Milligen de Wit, E B Haagsma, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseasesC P Denton, J E Pope, H-H Peter, et al.
Nature Genetics|July 12, 2005
Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humansU Salzer, H M Chapel, A D B Webster, et al.
Zeitschrift Fur Rheumatologie|November 10, 2012
[How I treat …]F Moosig, E Reinhold-Keller, K Holl-Ulrich, et al.
Clinical and Experimental Immunology|November 4, 2009
6th International Immunoglobulin Symposium: poster presentationsE Fernandez-Cruz, S V Kaveri, H-H Peter, et al.
Arthritis and Rheumatism|December 14, 2004
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonistJ H Korn, M Mayes, M Matucci Cerinic, et al.
Bone Marrow Transplantation|October 12, 1999
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune DiseaseA Tyndall, A Fassas, J Passweg, et al.
Klinische Padiatrie|November 13, 2012
[Interdisciplinary AWMF guideline for the treatment of primary antibody deficiencies]J Krudewig, U Baumann, H Bernuth von, et al.
Annals of the Rheumatic Diseases|May 15, 2001
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin diseaseM Binks, J R Passweg, D Furst, et al.
Pageof 37

Showing results (351-360 of 361) with videos related to

Sort By:
Pageof 37
The Journal of Rheumatology|August 24, 2000
Poly(ADP-ribose) polymerase polymorphisms are not a genetic risk factor for systemic lupus erythematosus in German CaucasiansP Boorboor, B E Drescher, K Hartung, et al.
The American Journal of Medicine|November 27, 1998
Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical featuresC Roozendaal, A W Van Milligen de Wit, E B Haagsma, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseasesC P Denton, J E Pope, H-H Peter, et al.
Nature Genetics|July 12, 2005
Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humansU Salzer, H M Chapel, A D B Webster, et al.
Zeitschrift Fur Rheumatologie|November 10, 2012
[How I treat …]F Moosig, E Reinhold-Keller, K Holl-Ulrich, et al.
Clinical and Experimental Immunology|November 4, 2009
6th International Immunoglobulin Symposium: poster presentationsE Fernandez-Cruz, S V Kaveri, H-H Peter, et al.
Arthritis and Rheumatism|December 14, 2004
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonistJ H Korn, M Mayes, M Matucci Cerinic, et al.
Bone Marrow Transplantation|October 12, 1999
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune DiseaseA Tyndall, A Fassas, J Passweg, et al.
Klinische Padiatrie|November 13, 2012
[Interdisciplinary AWMF guideline for the treatment of primary antibody deficiencies]J Krudewig, U Baumann, H Bernuth von, et al.
Annals of the Rheumatic Diseases|May 15, 2001
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin diseaseM Binks, J R Passweg, D Furst, et al.
Pageof 37